Molbio Diagnostics Share Price

Q: How to buy Molbio Diagnostics Share at Choice?

To buy Molbio Diagnostics stocks , log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Molbio Diagnostics, choose your preferred order type, and place the trade.

MOLBIO

Healthcare Large Cap

12460.20 (-0.02%)

NSE

BSE

Last updated on 25 Sep, 2026 | 15:56 IST

BuySell

Today's High

1259.60

Today's Low

1216.60

52 Week Low

926.35

52 Week High

1686.80

Free Demat with Zero AMC*

Summary

As of 28 Sep, 2026, Molbio Diagnostics stock price is ₹1246. During the trading session, the stock has moved between an intraday low of ₹1216.60 and an intraday high of ₹1259.60. Over the last 52 weeks, Molbio Diagnostics has traded between ₹926.35 and ₹1686.80.

The stock has recorded a trading volume of 5,38,647 shares,. Its Average Traded Price (ATP) is ₹1238.71, while the Last Traded Quantity at the Last Traded Price (LTQ@LTP) is 3 @ ₹1246.00.

Molbio Diagnostics has an upper circuit limit of ₹1495.20 and a lower circuit limit of ₹996.80. The total value traded stands at ₹66.72 CR, and the delivery percentage for the day is 23.41%.

The stock is currently traded with a market lot size of 1. Molbio Diagnostics also offers a dividend yield of 0%.

Molbio Diagnostics Share Price Chart

ChartIQ

TradingView

Molbio Diagnostics Share Key Metrics

Volume

5.39 L

Market Cap

14358.90 CR

LTQ@LTP

3@1246.00

ATP

1238.71

Var Margin

25 %

Circuit Range

996.8-1495.2

Delivery %

23.41 %

Value

66.72 CR

ASM/GSM

No

Market Lot

1

Molbio Diagnostics Fundamentals

P/E Ratio

86.2

P/B Ratio

10.1

Div. Yield

0

Sector P/E

53.85

Sector P/B

3.75

Sec. Div. Yield

0.05

Molbio Diagnostics Resistance and Support

Pivot 1265.93

Resistance

First Resistance

1301.86

Second Resistance

1357.53

Third Resistance

1393.46

Support

First Support

1210.26

Second Support

1174.33

Third Support

1118.66

Molbio Diagnostics Shareholding Pattern

2026-27

Segment

Percent

Total Promoters

41.29%

Mutual Fund

2.25%

Insurance

0.56%

Foreign Institutional Investors

1.51%

Domestic Institutional Investors

13.56%

Retail

40.82%

Others

0.01%

Total Promoters

JUN '26

AUG '26

41.29%

Molbio Diagnostics Historical Data

Day	Open	Close	Change(%)	Day High	Day Low
Fri Sep 25 2026	1247.5	1246	-0.02%	1259.6	1216.6
Thu Sep 24 2026	1304.19	1246.19	-5.10%	1321.59	1230
Wed Sep 23 2026	1274.69	1313.19	3.91%	1338.3	1260.19

Molbio Diagnostics Corporate Actions

Date	Agenda
2026-09-05	Quarterly Results

Molbio Diagnostics News

Molbio Diagnostics Ltd - 544866 - Revised Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011

India Business Excellence Fund III, a non-promoter group in Molbio Diagnostics, sold 3,000,000 shares via open market. This reduced their stake by 2.60% from 11.52% to 8.92%, triggering a SAST disclosure.

Sep 25 2026 13:14:54

Molbio Diagnostics Ltd - 544866 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011

India Business Excellence Fund III, a non-promoter entity, sold 30 lakh equity shares of Molbio Diagnostics via an open market transaction on September 23, 2026. This disposal resulted in a 2.60% reduction in its shareholding, bringing its total stake down to 8.92% from 11.52%.

Sep 25 2026 11:43:20

Molbio Diagnostics Ltd - 544866 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011

Molbio Diagnostics' non-promoter group, India Business Excellence Fund III, sold 30 lakh equity shares on Sep 23, 2026, through open market transactions. This reduced its total shareholding by 2.60% to 8.92%.

Sep 24 2026 15:05:06

Molbio Diagnostics Ltd - 544866 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

Molbio Diagnostics will conduct a virtual group meeting for investors and analysts on September 22, 2026, from 11:00 AM IST. The discussion will cover the general business outlook and public domain information, with no unpublished price sensitive information being disclosed.

Sep 17 2026 15:23:08

Molbio Diagnostics Ltd - 544866 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

Molbio Diagnostics announced strong Q1 FY27 financial results. Total income surged to Rs.411.48 cr, a substantial increase from Rs.100.47 cr in Q1 FY26, driven by higher Truenat test-kit volumes. The company also turned profitable with PAT of Rs.52.74 cr compared to a loss in the previous year.

Sep 07 2026 09:52:32

Molbio Diagnostics Ltd - 544866 - Board Meeting Outcome for Outcome Of Board Meeting.

Molbio Diagnostics board approved Q1 FY27 financial results on September 5, 2026. Standalone revenue reached ₹399.38 cr with net profit of ₹56.63 cr, while cons. revenue was ₹408.38 cr with net profit of ₹52.74 cr. Key Managerial Personnel were also authorized to determine materiality of events for disclosures.

Sep 05 2026 20:53:57

Molbio Diagnostics Ltd - 544866 - Board Meeting Intimation for To Consider And Approve The Financial Results For The Quarter Ended 30 June 2026.

Molbio Diagnostics will hold a board meeting on September 05, 2026. The board will consider and approve the standalone and consolidated financial results for the quarter ended June 30, 2026 (Q1 FY27).

Sep 01 2026 19:27:19

Name	Position
Sriram Natarajan	Executive Director & Chief Executive Officer
Sangeetha Sriram	Executive Director - Operations

Molbio Diagnostics Similar Stocks

Concord Biotech Ltd.

1453.60

-25.20 (1.70%)

Vijaya Diagnostic Centre Ltd.

1513.60

-12.90 (0.85%)

Marksans Pharma Ltd.

336.95

-0.45 (0.13%)

Dr. Agarwal's Health Care Ltd.

500.00

-2.10 (0.42%)

Natco Pharma Ltd.

839.30

-2.70 (0.32%)

Rainbow Children's Medicare Ltd.

1374.20

-38.40 (2.72%)

Sudeep Pharma Ltd.

1164.90

21.50 (1.88%)

CORONA Remedies Ltd.

2117.70

6.70 (0.32%)

Akums Drugs & Pharmaceuticals Ltd.

819.55

1.95 (0.24%)

Molbio Diagnostics FAQs

The Buying Price of Molbio Diagnostics share is 1246 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.

To buy Molbio Diagnostics stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Molbio Diagnostics, choose your preferred order type, and place the trade.

The Price-to-earnings (P/E) ratio of Molbio Diagnostics shares is 86.2. You can compare it with the sector average for relative valuation.

The Price to Book (P/B) ratio Molbio Diagnostics shares is 10.1. Useful to assess the stock's value relative to its book value.

To assess Molbio Diagnostics’s valuation compare Sector P/E, P/B which are 53.85 & 3.75 with sector averages, along with growth rates and financial metrics.

The Market Cap of Molbio Diagnostics is 14358.90 CR. It indicates the company's size category and trading liquidity.

The 52 week high and low prices of Molbio Diagnostics share price is 1686.80 & 926.35. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.

Molbio Diagnostics belongs to the Healthcare sector.